Cite
HARVARD Citation
Miroddi, M. et al. (2015). Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials. Critical reviews in oncology/hematology. 96 (2), pp. 355-371. [Online].